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Abstract 
The antimalarials are one of the most commonly prescribed drugs for conditions such as lupus erythematosus and 
rheumatoid arthritis, and the side effects, though infrequent, are well known. The antimalarial agent chloroquine 
diphosphate usually causes pigmentary changes in the oral mucosa characterized by a bluish-grey to black disco-
lorations mainly in the hard palate. Considering only the hard palate hyperpigmentation caused by chloroquine, to 
the best of our knowledge, only 13 cases have been reported in the English language literature. We described an 
additional case of palate hyperpigmentation related to the chronic use of chloroquine diphosphate in a 60-year-old 
Mexican woman. Although the diagnosis is usually made based on medication history and clinical presentation, a 
biopsy specimen may be helpful to confirm the diagnosis. Clinicians must be aware of these drugs and their adverse 
effects in order to make the correct diagnosis and decide on the optimal treatment for the condition.
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Introduction
Oral mucosal pigmentation is a common finding, usua-
lly associated with normal melanin deposition in dark-
skinned people. A wide variety of lesions and conditions 
are associated with abnormal mucosal discoloration. 
Isolated and well-circumscribed oral pigmented lesions 
are usually diagnosed as melanotic macule, melanocytic 
nevus or amalgam tattoo, or more uncommonly as an 
initial sign of melanoma. Diffuse or multifocal muco-
sal hyperpigmentation may be a sign of systemic disea-
se such as Addison’s disease, Peutz–Jeghers syndrome, 
melanoplakia and human immunodeficiency virus (HIV) 
infection, or a side effect of drug therapy (1-5). 
Drugs associated with abnormal oral pigmentation in-
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clude tetracycline, zidovudine, anti-inflammatory drugs 
and antimalarial agents, such as quinacrine hydrochlori-
de, chloroquine, hydroxychloroquine, and amodiaquine 
(6). In addition to treating malaria, these medications 
are used for management of systemic and discoid lupus 
erythematosus and rheumatoid arthritis (7-18). Clini-
cians will most likely encounter patients taking these 
medications and should, therefore, be familiar with this 
potential oral side effect (1). Early diagnosis of oral pig-
mentation by antimalarials may be of great relevance, 
since it might be an early sign of ocular involvement, 
and therefore it may be helpful to prevent further com-
plications of antimalarial therapy for the patient (1). 
We describe an additional case of hard palate hyperpig-
mentation related to the chronic use of chloroquine di-
phosphate for rheumatoid arthritis treatment. 
Case Report
A 60-year-old Mexican woman was referred for eva-
luation of a diffuse blue-gray pigmentation of the hard 
palate lasting six months. Her medical history revealed 
that she had been undergoing treatment with chloroqui-
ne diphosphate (150mg/day) for rheumatoid arthritis for 
1 year. Clinical examination showed a 4 cm blue-gray 
pigmented diffuse lesion with irregular borders on the 
hard palate (Fig. 1). The pigmented area did not blanch 
Fig. 1: Clinical aspect of hyperpigmentation of hard palate induced 
by chloroquine therapy showing a blue-gray pigmented diffuse le-
sion with irregular borders. 
with pressure. On extra-oral examination, pigmentation 
was not seen in the skin or in the ocular conjunctiva. 
Differential diagnosis included drug-induced hyperpig-
mentation, Addison’s disease, vitamin B12 deficiency, 
and melanoma. The history of long-term chloroquine 
use, led to the clinical working diagnosis of drug-indu-
ced oral pigmentation caused by chloroquine diphospha-
te. To confirm this, an incisional biopsy was taken from 
the hard palate mucosa and sent for histopathological 
examination.
Microscopical evaluation showed a subepithelial depo-
sition of granular pigment mainly located between co-
llagen fibers and within fibroblasts and macrophages. 
Staining with Perls’ confirmed that the pigment was he-
mosiderin. Fontana-Masson stain was also positive con-
firming the presence of melanin (Fig. 2). Immunohis-
tochemistry with CD68 (dilution 1:400, clone PGM-1, 
Dako, Carpinteria, CA, USA) highlighted macrophages 
containing intracellular pigment (Fig. 2). These histo-
pathological findings and the clinical appearance of 
the lesion confirmed the diagnosis of drug-induced oral 
pigmentation caused by chloroquine diphosphate. The 
drug was discontinued and the patient was referred for 
ophthalmologic evaluation that showed no signs of re-
tinopathy.
Discussion
Oral mucosal pigmentation can be result of a wide va-
riety of lesions and conditions. A systematic evaluation, 
including a complete and accurate patient history and a 
thorough clinical examination, is essential for the appro-
priate differential diagnosis (2). Brown, black, or gray 
discoloration is most often caused by an accumulation 
of melanin, hemosiderin, or foreign body material, whe-
reas red, blue, or purple color changes suggest a vascular 
process (2). Multifocal or diffuse distribution of pigmen-
tation suggests a systemic cause, such as a metabolic 
disorder or drug toxicity. Antimalarial agents, such as 
chloroquine diphosphate and hydroxychloroquine sul-
fate, are administered for treatment of several dermato-
logic and rheumatologic disorders, and they are known 
to cause hyperpigmentation of the oral mucosa (9,15). 
Systemic administration of these drugs for a prolonged 
period is responsible for the appearance of multifocal 
hyperpigmentation, which is reversible once the medi-
cation is discontinued. Oral pigmentation secondary to 
drug therapy can be attributed to the stimulation of me-
lanin production by melanocytes and/or the deposition 
of hemosiderin in the tissues (1,2,5).
Lippard and Kauer first described pigmentation of palatal 
mucosa resulting from antimalarial medication in 1945 
(10). Since then, it has been reported by others (1,5,10,11). 
In most cases, only the hard palate is involved, forming a 
sharp line of demarcation at the junction of the hard and 
soft palates (2). An explanation for sparing the soft palate 
has not been offered. Involvement of gingiva and labial 
or buccal mucosa has also been reported (4). Considering 
only the hard palate hyperpigmentation caused by chloro-
quine, to the best of our knowledge, only 13 cases have 
been reported in the English language literature (Table 1) 
(1,3-5,12,16-18). Skin pigmentation can also be obser-
ved in patients undergoing treatment with chloroquine 
diphosphate (2) as well as reversible graying of the scalp 
hair, beard, eyelashes, and eyebrows (14). Pigmentary 
changes in the oral mucosa can also be associated with 
other medicaments including tranquilizers (chlorproma-
zine), chemotherapeutics (doxorubicin, busulfan, and 
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Fig. 2: Histological aspects of hyperpigmentation of hard palate induced by chloroquine ther-
apy. A – Subepithelial deposition of granular pigment mainly located between collagen fibers 
and within fibroblasts and macrophages (HE, 400X). B – Staining with Perls’ confirmed that 
the pigment present in the lesion is constituted by hemosiderin (Perls’ stain, 400X). C – The 
pigment deposits were also positive for Fontana-Masson stain (400X). D – Immunohistochemi-
cal aspects of hyperpigmentation of hard palate induced by chloroquine therapy. Presence of 
intracellular dark-brown pigment in the macrophages with CD68 (Permanet red, 400X).
cyclophosphamide), anti-retroviral agents (zidovudine, 
AZT), antifungal agents ketoconazole), antibiotics (mi-
nocycline), and laxatives (phenolphthalein) (13). In the 
current case, the hyperpigmentation was localized only in 
the hard patale without cutaneous involvement.   
It is important to note that several systemic disorders can 
promote oral and cutaneous pigmentation and this should 
be further explored through the medical history. Syste-
mic causes that need to be considered include adrenal in-
sufficiency, Peutz- Jeghers syndrome, hemochromatosis, 
polyostotic fibrous dysplasia, hyperparathyroidism, and 
neurofibromatosis (2). Abnormal pigmentation is relati-
vely common in individuals infected with the human im-
munodeficiency virus (HIV). In some HIV-related cases, 
pigmentation has been associated with drug therapy or 
adrenal insufficiency; however, in many cases the cause 
cannot be identified (15).
The greatest significance of chloroquine-induced hyper-
pigmentation is the possibility that it may be a marker 
for a more serious side effect. Irreversible retinopathy 
which in some cases leads to blindness, is recognized 
as a potential complication of antimalarial drug therapy 
and it has been suggested that abnormal skin and muco-
sal pigmentation may be an indication of ocular involve-
ment (2,3). Based on this potentially severe complica-
tion, periodic evaluation is necessary for patients being 
treated with ongoing antimalarial therapy. Our patient 
was evaluated by an ophthalmologist showing no signs 
of retinopathy.
The diagnosis of drug-induced hyperpigmentation is of-
ten made based on medication history and clinical pre-
sentation. In cases which clinical features are atypical or 
a complete medication history is not available, a biopsy 
should be performed to establish the diagnosis (2). Biop-
sy is particularly important to rule out melanoma, which 
may initially present as hyperpigmentation of otherwise 
normal appearing mucosa (2,5).
In chloroquine-induced hyperpigmentation, biopsy spe-
cimens of involved mucosa may exhibit gross subepi-
thelial pigmentation (1). Hematoxylin-eosin stained 
sections demonstrate deposits of granular pigmentation 
extracellular or within fibroblasts and macrophages 
scattered throughout the lamina propria. Histochemical 
stains have been used in an attempt to identify the nature 
of the pigmentation; however, results have been incon-
sistent. Authors have identified melanin, hemosiderin, or 
both (1,5). In our case we confirmed presence of hemo-
siderin and melanin as the pigment was positive with 
wither Perls’ and Fontana Masson stainings. 
For this type of oral pigmentation, no treatment is re-
quired. The management involves, if possible, discon-
tinuing the medication or decreasing the dosage, and it 
has been recommended that these patients also be refe-
rred to an ophthalmologist (1,3). 
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In summary, diffuse oral pigmentation can be a sign of 
drug side effect and should be included as part of the cli-
nical differential diagnosis of hyperpigmentation of the 
oral mucosa.  Antimalarial agents such as chloroquine 
are among the drugs more commonly associated with 
this mucosal alteration. Although the diagnosis is usua-
lly made based on medication history and clinical pre-
sentation, a biopsy specimen may be helpful to confirm 
the diagnosis. The management involves discontinuing 
or decreasing use of the drug and referral for ophthal-
mologic examination.
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